CoreCap Advisors’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-108
| Closed | -$1.45K | – | 2660 |
|
|
2024
Q2 | $1.45K | Hold |
108
| – | – | ﹤0.01% | 1361 |
|
|
2024
Q1 | $1.79K | Buy |
+108
| New | +$1.79K | ﹤0.01% | 2145 |
|
|
2022
Q4 | $42.7K | Buy |
+3,107
| New | +$42.7K | ﹤0.01% | 1039 |
|
|
2022
Q3 | – | Sell |
-9,107
| Closed | -$138K | – | 812 |
|
|
2022
Q2 | $138K | Buy |
+9,107
| New | +$138K | 0.01% | 596 |
|
|
2022
Q1 | – | Sell |
-5,100
| Closed | -$121K | – | 827 |
|
|
2021
Q4 | $121K | Buy |
+5,100
| New | +$121K | 0.01% | 678 |
|